CD4 and gastric cancer: Morphine suppresses the immune function of gastric cancer patients by regulating the percentage of CD4+, CD25+, FoxP3+ regulatory T lymphocytes (Tregs) in vitro and increasing the CD4+/CD8+ ratio and Tregs (25).